 | • レポートコード：MRC2-11QY12089 • 出版社/出版日：QYResearch / 2020年11月25日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は有毛細胞白血病治療薬のグローバル市場について調査・分析したレポートです。種類別（デザペリシブ、ELB-021、イブルチニブ、AGS-67E、ARABS-4、その他）市場規模、用途別（病院、クリニック、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別有毛細胞白血病治療薬の競争状況、市場シェア ・世界の有毛細胞白血病治療薬市場：種類別市場規模 2015年-2020年（デザペリシブ、ELB-021、イブルチニブ、AGS-67E、ARABS-4、その他） ・世界の有毛細胞白血病治療薬市場：種類別市場規模予測 2021年-2026年（デザペリシブ、ELB-021、イブルチニブ、AGS-67E、ARABS-4、その他） ・世界の有毛細胞白血病治療薬市場：用途別市場規模 2015年-2020年（病院、クリニック、その他） ・世界の有毛細胞白血病治療薬市場：用途別市場規模予測 2021年-2026年（病院、クリニック、その他） ・北米の有毛細胞白血病治療薬市場分析：米国、カナダ ・ヨーロッパの有毛細胞白血病治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの有毛細胞白血病治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の有毛細胞白血病治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの有毛細胞白血病治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：AbbVie Inc、ARA Healthcare Pvt Ltd、Astellas Pharma Inc.、Cellectis SA、F. Hoffmann-La Roche Ltd、Incyte Corp、Juno Therapeutics Inc、MedImmune LLC、Novartis AG ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Hairy Cell Leukemia Therapeutics Market
The global Hairy Cell Leukemia Therapeutics market size is projected to reach US$ 90 million by 2026, from US$ 86 million in 2020, at a CAGR of 4.8%% during 2021-2026.
Global Hairy Cell Leukemia Therapeutics Scope and Market Size
Hairy Cell Leukemia Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Hairy Cell Leukemia Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
AbbVie Inc
ARA Healthcare Pvt Ltd
Astellas Pharma Inc.
Cellectis SA
F. Hoffmann-La Roche Ltd
Incyte Corp
Juno Therapeutics Inc
MedImmune LLC
Novartis AG
Market segment by Type, the product can be split into
Dezapelisib
ELB-021
Ibrutinib
AGS-67E
ARABS-4
Others
Market segment by Application, split into
Hospital
Clinic
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Hairy Cell Leukemia Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Hairy Cell Leukemia Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Dezapelisib
1.4.3 ELB-021
1.4.4 Ibrutinib
1.4.5 AGS-67E
1.4.6 ARABS-4
1.4.7 Others
1.5 Market by Application
1.5.1 Global Hairy Cell Leukemia Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Hairy Cell Leukemia Therapeutics Market Perspective (2015-2026)
2.2 Global Hairy Cell Leukemia Therapeutics Growth Trends by Regions
2.2.1 Hairy Cell Leukemia Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Hairy Cell Leukemia Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Hairy Cell Leukemia Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Hairy Cell Leukemia Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Hairy Cell Leukemia Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Hairy Cell Leukemia Therapeutics Players by Market Size
3.1.1 Global Top Hairy Cell Leukemia Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Hairy Cell Leukemia Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Hairy Cell Leukemia Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Hairy Cell Leukemia Therapeutics Market Concentration Ratio
3.2.1 Global Hairy Cell Leukemia Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Hairy Cell Leukemia Therapeutics Revenue in 2019
3.3 Hairy Cell Leukemia Therapeutics Key Players Head office and Area Served
3.4 Key Players Hairy Cell Leukemia Therapeutics Product Solution and Service
3.5 Date of Enter into Hairy Cell Leukemia Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Hairy Cell Leukemia Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Hairy Cell Leukemia Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Hairy Cell Leukemia Therapeutics Market Size by Application (2015-2020)
5.2 Global Hairy Cell Leukemia Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Hairy Cell Leukemia Therapeutics Market Size (2015-2020)
6.2 Hairy Cell Leukemia Therapeutics Key Players in North America (2019-2020)
6.3 North America Hairy Cell Leukemia Therapeutics Market Size by Type (2015-2020)
6.4 North America Hairy Cell Leukemia Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Hairy Cell Leukemia Therapeutics Market Size (2015-2020)
7.2 Hairy Cell Leukemia Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Hairy Cell Leukemia Therapeutics Market Size by Type (2015-2020)
7.4 Europe Hairy Cell Leukemia Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Hairy Cell Leukemia Therapeutics Market Size (2015-2020)
8.2 Hairy Cell Leukemia Therapeutics Key Players in China (2019-2020)
8.3 China Hairy Cell Leukemia Therapeutics Market Size by Type (2015-2020)
8.4 China Hairy Cell Leukemia Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Hairy Cell Leukemia Therapeutics Market Size (2015-2020)
9.2 Hairy Cell Leukemia Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Hairy Cell Leukemia Therapeutics Market Size by Type (2015-2020)
9.4 Japan Hairy Cell Leukemia Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Hairy Cell Leukemia Therapeutics Market Size (2015-2020)
10.2 Hairy Cell Leukemia Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Hairy Cell Leukemia Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Hairy Cell Leukemia Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Hairy Cell Leukemia Therapeutics Market Size (2015-2020)
11.2 Hairy Cell Leukemia Therapeutics Key Players in India (2019-2020)
11.3 India Hairy Cell Leukemia Therapeutics Market Size by Type (2015-2020)
11.4 India Hairy Cell Leukemia Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Hairy Cell Leukemia Therapeutics Market Size (2015-2020)
12.2 Hairy Cell Leukemia Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Hairy Cell Leukemia Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Hairy Cell Leukemia Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 AbbVie Inc
13.1.1 AbbVie Inc Company Details
13.1.2 AbbVie Inc Business Overview
13.1.3 AbbVie Inc Hairy Cell Leukemia Therapeutics Introduction
13.1.4 AbbVie Inc Revenue in Hairy Cell Leukemia Therapeutics Business (2015-2020))
13.1.5 AbbVie Inc Recent Development
13.2 ARA Healthcare Pvt Ltd
13.2.1 ARA Healthcare Pvt Ltd Company Details
13.2.2 ARA Healthcare Pvt Ltd Business Overview
13.2.3 ARA Healthcare Pvt Ltd Hairy Cell Leukemia Therapeutics Introduction
13.2.4 ARA Healthcare Pvt Ltd Revenue in Hairy Cell Leukemia Therapeutics Business (2015-2020)
13.2.5 ARA Healthcare Pvt Ltd Recent Development
13.3 Astellas Pharma Inc.
13.3.1 Astellas Pharma Inc. Company Details
13.3.2 Astellas Pharma Inc. Business Overview
13.3.3 Astellas Pharma Inc. Hairy Cell Leukemia Therapeutics Introduction
13.3.4 Astellas Pharma Inc. Revenue in Hairy Cell Leukemia Therapeutics Business (2015-2020)
13.3.5 Astellas Pharma Inc. Recent Development
13.4 Cellectis SA
13.4.1 Cellectis SA Company Details
13.4.2 Cellectis SA Business Overview
13.4.3 Cellectis SA Hairy Cell Leukemia Therapeutics Introduction
13.4.4 Cellectis SA Revenue in Hairy Cell Leukemia Therapeutics Business (2015-2020)
13.4.5 Cellectis SA Recent Development
13.5 F. Hoffmann-La Roche Ltd
13.5.1 F. Hoffmann-La Roche Ltd Company Details
13.5.2 F. Hoffmann-La Roche Ltd Business Overview
13.5.3 F. Hoffmann-La Roche Ltd Hairy Cell Leukemia Therapeutics Introduction
13.5.4 F. Hoffmann-La Roche Ltd Revenue in Hairy Cell Leukemia Therapeutics Business (2015-2020)
13.5.5 F. Hoffmann-La Roche Ltd Recent Development
13.6 Incyte Corp
13.6.1 Incyte Corp Company Details
13.6.2 Incyte Corp Business Overview
13.6.3 Incyte Corp Hairy Cell Leukemia Therapeutics Introduction
13.6.4 Incyte Corp Revenue in Hairy Cell Leukemia Therapeutics Business (2015-2020)
13.6.5 Incyte Corp Recent Development
13.7 Juno Therapeutics Inc
13.7.1 Juno Therapeutics Inc Company Details
13.7.2 Juno Therapeutics Inc Business Overview
13.7.3 Juno Therapeutics Inc Hairy Cell Leukemia Therapeutics Introduction
13.7.4 Juno Therapeutics Inc Revenue in Hairy Cell Leukemia Therapeutics Business (2015-2020)
13.7.5 Juno Therapeutics Inc Recent Development
13.8 MedImmune LLC
13.8.1 MedImmune LLC Company Details
13.8.2 MedImmune LLC Business Overview
13.8.3 MedImmune LLC Hairy Cell Leukemia Therapeutics Introduction
13.8.4 MedImmune LLC Revenue in Hairy Cell Leukemia Therapeutics Business (2015-2020)
13.8.5 MedImmune LLC Recent Development
13.9 Novartis AG
13.9.1 Novartis AG Company Details
13.9.2 Novartis AG Business Overview
13.9.3 Novartis AG Hairy Cell Leukemia Therapeutics Introduction
13.9.4 Novartis AG Revenue in Hairy Cell Leukemia Therapeutics Business (2015-2020)
13.9.5 Novartis AG Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Hairy Cell Leukemia Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Hairy Cell Leukemia Therapeutics Revenue
Table 3. Ranking of Global Top Hairy Cell Leukemia Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Hairy Cell Leukemia Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Dezapelisib
Table 6. Key Players of ELB-021
Table 7. Key Players of Ibrutinib
Table 8. Key Players of AGS-67E
Table 9. Key Players of ARABS-4
Table 10. Key Players of Others
Table 11. Global Hairy Cell Leukemia Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Hairy Cell Leukemia Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Hairy Cell Leukemia Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Hairy Cell Leukemia Therapeutics Market Share by Regions (2015-2020)
Table 15. Global Hairy Cell Leukemia Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Hairy Cell Leukemia Therapeutics Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Hairy Cell Leukemia Therapeutics Market Growth Strategy
Table 21. Main Points Interviewed from Key Hairy Cell Leukemia Therapeutics Players
Table 22. Global Hairy Cell Leukemia Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 23. Global Hairy Cell Leukemia Therapeutics Market Share by Players (2015-2020)
Table 24. Global Top Hairy Cell Leukemia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hairy Cell Leukemia Therapeutics as of 2019)
Table 25. Global Hairy Cell Leukemia Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Hairy Cell Leukemia Therapeutics Product Solution and Service
Table 28. Date of Enter into Hairy Cell Leukemia Therapeutics Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Hairy Cell Leukemia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 31. Global Hairy Cell Leukemia Therapeutics Market Size Share by Type (2015-2020)
Table 32. Global Hairy Cell Leukemia Therapeutics Revenue Market Share by Type (2021-2026)
Table 33. Global Hairy Cell Leukemia Therapeutics Market Size Share by Application (2015-2020)
Table 34. Global Hairy Cell Leukemia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 35. Global Hairy Cell Leukemia Therapeutics Market Size Share by Application (2021-2026)
Table 36. North America Key Players Hairy Cell Leukemia Therapeutics Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Hairy Cell Leukemia Therapeutics Market Share (2019-2020)
Table 38. North America Hairy Cell Leukemia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 39. North America Hairy Cell Leukemia Therapeutics Market Share by Type (2015-2020)
Table 40. North America Hairy Cell Leukemia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 41. North America Hairy Cell Leukemia Therapeutics Market Share by Application (2015-2020)
Table 42. Europe Key Players Hairy Cell Leukemia Therapeutics Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Hairy Cell Leukemia Therapeutics Market Share (2019-2020)
Table 44. Europe Hairy Cell Leukemia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Hairy Cell Leukemia Therapeutics Market Share by Type (2015-2020)
Table 46. Europe Hairy Cell Leukemia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Hairy Cell Leukemia Therapeutics Market Share by Application (2015-2020)
Table 48. China Key Players Hairy Cell Leukemia Therapeutics Revenue (2019-2020) (Million US$)
Table 49. China Key Players Hairy Cell Leukemia Therapeutics Market Share (2019-2020)
Table 50. China Hairy Cell Leukemia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 51. China Hairy Cell Leukemia Therapeutics Market Share by Type (2015-2020)
Table 52. China Hairy Cell Leukemia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 53. China Hairy Cell Leukemia Therapeutics Market Share by Application (2015-2020)
Table 54. Japan Key Players Hairy Cell Leukemia Therapeutics Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Hairy Cell Leukemia Therapeutics Market Share (2019-2020)
Table 56. Japan Hairy Cell Leukemia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Hairy Cell Leukemia Therapeutics Market Share by Type (2015-2020)
Table 58. Japan Hairy Cell Leukemia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Hairy Cell Leukemia Therapeutics Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Hairy Cell Leukemia Therapeutics Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Hairy Cell Leukemia Therapeutics Market Share (2019-2020)
Table 62. Southeast Asia Hairy Cell Leukemia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Hairy Cell Leukemia Therapeutics Market Share by Type (2015-2020)
Table 64. Southeast Asia Hairy Cell Leukemia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Hairy Cell Leukemia Therapeutics Market Share by Application (2015-2020)
Table 66. India Key Players Hairy Cell Leukemia Therapeutics Revenue (2019-2020) (Million US$)
Table 67. India Key Players Hairy Cell Leukemia Therapeutics Market Share (2019-2020)
Table 68. India Hairy Cell Leukemia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 69. India Hairy Cell Leukemia Therapeutics Market Share by Type (2015-2020)
Table 70. India Hairy Cell Leukemia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 71. India Hairy Cell Leukemia Therapeutics Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Hairy Cell Leukemia Therapeutics Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Hairy Cell Leukemia Therapeutics Market Share (2019-2020)
Table 74. Central & South America Hairy Cell Leukemia Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Hairy Cell Leukemia Therapeutics Market Share by Type (2015-2020)
Table 76. Central & South America Hairy Cell Leukemia Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Hairy Cell Leukemia Therapeutics Market Share by Application (2015-2020)
Table 78. AbbVie Inc Company Details
Table 79. AbbVie Inc Business Overview
Table 80. AbbVie Inc Product
Table 81. AbbVie Inc Revenue in Hairy Cell Leukemia Therapeutics Business (2015-2020) (Million US$)
Table 82. AbbVie Inc Recent Development
Table 83. ARA Healthcare Pvt Ltd Company Details
Table 84. ARA Healthcare Pvt Ltd Business Overview
Table 85. ARA Healthcare Pvt Ltd Product
Table 86. ARA Healthcare Pvt Ltd Revenue in Hairy Cell Leukemia Therapeutics Business (2015-2020) (Million US$)
Table 87. ARA Healthcare Pvt Ltd Recent Development
Table 88. Astellas Pharma Inc. Company Details
Table 89. Astellas Pharma Inc. Business Overview
Table 90. Astellas Pharma Inc. Product
Table 91. Astellas Pharma Inc. Revenue in Hairy Cell Leukemia Therapeutics Business (2015-2020) (Million US$)
Table 92. Astellas Pharma Inc. Recent Development
Table 93. Cellectis SA Company Details
Table 94. Cellectis SA Business Overview
Table 95. Cellectis SA Product
Table 96. Cellectis SA Revenue in Hairy Cell Leukemia Therapeutics Business (2015-2020) (Million US$)
Table 97. Cellectis SA Recent Development
Table 98. F. Hoffmann-La Roche Ltd Company Details
Table 99. F. Hoffmann-La Roche Ltd Business Overview
Table 100. F. Hoffmann-La Roche Ltd Product
Table 101. F. Hoffmann-La Roche Ltd Revenue in Hairy Cell Leukemia Therapeutics Business (2015-2020) (Million US$)
Table 102. F. Hoffmann-La Roche Ltd Recent Development
Table 103. Incyte Corp Company Details
Table 104. Incyte Corp Business Overview
Table 105. Incyte Corp Product
Table 106. Incyte Corp Revenue in Hairy Cell Leukemia Therapeutics Business (2015-2020) (Million US$)
Table 107. Incyte Corp Recent Development
Table 108. Juno Therapeutics Inc Company Details
Table 109. Juno Therapeutics Inc Business Overview
Table 110. Juno Therapeutics Inc Product
Table 111. Juno Therapeutics Inc Revenue in Hairy Cell Leukemia Therapeutics Business (2015-2020) (Million US$)
Table 112. Juno Therapeutics Inc Recent Development
Table 113. MedImmune LLC Business Overview
Table 114. MedImmune LLC Product
Table 115. MedImmune LLC Company Details
Table 116. MedImmune LLC Revenue in Hairy Cell Leukemia Therapeutics Business (2015-2020) (Million US$)
Table 117. MedImmune LLC Recent Development
Table 118. Novartis AG Company Details
Table 119. Novartis AG Business Overview
Table 120. Novartis AG Product
Table 121. Novartis AG Revenue in Hairy Cell Leukemia Therapeutics Business (2015-2020) (Million US$)
Table 122. Novartis AG Recent Development
Table 123. Research Programs/Design for This Report
Table 124. Key Data Information from Secondary Sources
Table 125. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hairy Cell Leukemia Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Dezapelisib Features
Figure 3. ELB-021 Features
Figure 4. Ibrutinib Features
Figure 5. AGS-67E Features
Figure 6. ARABS-4 Features
Figure 7. Others Features
Figure 8. Global Hairy Cell Leukemia Therapeutics Market Share by Application: 2020 VS 2026
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. Hairy Cell Leukemia Therapeutics Report Years Considered
Figure 13. Global Hairy Cell Leukemia Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Hairy Cell Leukemia Therapeutics Market Share by Regions: 2020 VS 2026
Figure 15. Global Hairy Cell Leukemia Therapeutics Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Hairy Cell Leukemia Therapeutics Market Share by Players in 2019
Figure 18. Global Top Hairy Cell Leukemia Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hairy Cell Leukemia Therapeutics as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Hairy Cell Leukemia Therapeutics Revenue in 2019
Figure 20. North America Hairy Cell Leukemia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Hairy Cell Leukemia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Hairy Cell Leukemia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Hairy Cell Leukemia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Hairy Cell Leukemia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Hairy Cell Leukemia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Hairy Cell Leukemia Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
有毛細胞白血病治療の世界市場（～2026年） Hairy cell leukemia is a rare type of cancer of blood which is caused due to abnormal growth of B cells. It has been observed that out of all the leukemia’s, hairy cell leukemia accounts for about 2% and thus eventually must be treated after its prominent symptoms. The drivers for the HCL market can…- 成人T細胞白血病/リンパ腫治療の世界市場（～2026年） Adult T-cell lymphoma/leukemia (ATL) is a rare T-cell lymphoproliferative neoplasm caused by human T-lymphotrophic virus 1. In its more common, aggressive forms, ATL carries one of the poorest prognoses of the non-Hodgkin lymphomas. The disease has clinical subtypes (ie, acute, lymphoma, chronic, an…
- 慢性リンパ性白血病（CLL）治療薬の世界市場（～2026年） Market Analysis and Insights: Global Chronic Lymphocytic Leukemia Therapeutics Market The global Chronic Lymphocytic Leukemia Therapeutics market size is projected to reach US$ 9390.9 million by 2026, from US$ 8411.2 million in 2020, at a CAGR of 10.8%% during 2021-2026. Global Chronic Lymphocytic L…
- 急性骨髄性白血病治療薬の世界市場（～2026年） Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from birth to 19 years of age diagnosed with leukemia have acute myeloid leukemia. The risk of acute myeloid leukemia is closely associated with age. About 90…
- B細胞慢性リンパ球性白血病治療の世界市場（～2026年） Market Analysis and Insights: Global B-Cell Chronic Lymphocytic Leukemia Treatment Market The global B-Cell Chronic Lymphocytic Leukemia Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global B-Cell Chronic Lymphocy…